Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Working Capital Changes: 2010-2019

Historic Other Working Capital Changes for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$15,000.

  • EyePoint Pharmaceuticals' Other Working Capital Changes fell 102.80% to -$15,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$15,000, marking a year-over-year decrease of 105.77%. This contributed to the annual value of -$30.6 million for FY2024, which is 168.83% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Other Working Capital Changes stood at -$15,000 for Q4 2019, which was up 50.00% from -$30,000 recorded in Q1 2019.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Working Capital Changes peaked at $535,000 during Q4 2018, and registered a low of -$505,000 during Q2 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Other Working Capital Changes averaged around $9,889, with its median value being -$30,000 (2019).
  • The largest annual percentage gain for EyePoint Pharmaceuticals' Other Working Capital Changes in the last 5 years was 16,600.00% (2017), contrasted with its biggest fall of 400.00% (2017).
  • EyePoint Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$9,000 in 2015, then surged by 66.67% to -$3,000 in 2016, then surged by 16,600.00% to $495,000 in 2017, then increased by 8.08% to $535,000 in 2018, then slumped by 102.80% to -$15,000 in 2019.
  • Its Other Working Capital Changes stands at -$15,000 for Q4 2019, versus -$30,000 for Q1 2019 and $535,000 for Q4 2018.